Berenberg Bank Analysts Give Carl Zeiss Meditec (ETR:AFX) a €93.00 Price Target

Berenberg Bank set a €93.00 ($108.14) target price on Carl Zeiss Meditec (ETR:AFX) in a research note issued to investors on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

A number of other research analysts have also recently issued reports on AFX. Nord/LB set a €8.50 ($9.88) price target on shares of Commerzbank and gave the company a neutral rating in a research report on Wednesday, May 8th. Hauck & Aufhaeuser set a €72.00 ($83.72) price target on shares of Stroeer SE & Co KGaA and gave the company a buy rating in a research report on Monday, April 15th. Independent Research set a €85.00 ($98.84) price target on shares of Henkel AG & Co KGaA and gave the company a sell rating in a research report on Tuesday, May 7th. Deutsche Bank lifted their price target on shares of Walmart from $118.00 to $120.00 and gave the company a buy rating in a research report on Friday, May 17th. Finally, HSBC lowered their price target on shares of Canada Goose from C$62.00 to C$55.00 and set a buy rating for the company in a research report on Monday, June 3rd. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. The company has an average rating of Hold and a consensus price target of €81.19 ($94.40).

ETR:AFX opened at €97.50 ($113.37) on Wednesday. The stock has a 50-day moving average of €87.80. Carl Zeiss Meditec has a 12 month low of €60.25 ($70.06) and a 12 month high of €98.60 ($114.65). The company has a debt-to-equity ratio of 4.55, a quick ratio of 3.09 and a current ratio of 4.11. The stock has a market cap of $8.72 billion and a PE ratio of 67.99.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Read More: Fundamental Analysis and Individual Investors

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.